In diabetic nephropathy, the expression of KIM1 is high, but (−)-epigallocatechin gallate intake has been shown to ameliorate hyperglycemia, hyperlipidemia, AGEs, renal pathological changes, renal dysfunction, and abnormal KIM1 protein expression. Here, HAVCR1 is linked to hyperlipidemia.